22 filings
8-K
ODTC
Odonate Therapeutics, Inc.
7 Jan 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:00am
8-K
ODTC
Odonate Therapeutics, Inc.
18 Nov 21
Odonate Therapeutics Announces Planned Return of Capital to Stockholders through Share Repurchase Plan
5:00pm
8-K
ODTC
Odonate Therapeutics, Inc.
5 Aug 21
Departure of Directors or Certain Officers
4:33pm
8-K
ODTC
Odonate Therapeutics, Inc.
25 Jun 21
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
ODTC
Odonate Therapeutics, Inc.
25 Mar 21
Cost Associated with Exit or Disposal Activities
4:18pm
8-K
q7456f
23 Feb 21
Entry into a Material Definitive Agreement
8:28am
8-K
21n22z6
15 Dec 20
Departure of Directors or Certain Officers
4:15pm
8-K
jc85 yhnm8rbf
15 Dec 20
Other Events
12:00am
8-K
30dux4fl 8v
14 Dec 20
Other Events
4:26pm
8-K
8wow h96hm
4 Nov 20
Changes in Registrant's Certifying Accountant
4:15pm
8-K
omv 154mzcxx6
1 Sep 20
Entry into a Material Definitive Agreement
4:14pm
8-K
4gbbu q0dr5
24 Aug 20
Odonate Therapeutics Announces Positive Top‑line Results from CONTESSA, a Phase 3 Study of Tesetaxel in Patients with Metastatic Breast Cancer
4:01pm
8-K
wzbchn x4541
26 Jun 20
Submission of Matters to a Vote of Security Holders
8:00am
8-K
4gmlj
25 Nov 19
Departure of Directors or Certain Officers
9:01am
8-K
iuuzynpi
27 Sep 19
Departure of Directors or Certain Officers
4:05pm
8-K
2crlvs58mu0hb553
24 Jul 19
Submission of Matters to a Vote of Security Holders
8:30am
8-K
jwve8y 06
28 Jun 19
Entry into a Material Definitive Agreement
4:35pm
8-K
e9yf4 xo3sy1r6
24 Jun 19
Amendments to Articles of Incorporation or Bylaws
8:00am
8-K
ogft5ufw4nt1v
6 Dec 18
Departure of Directors or Certain Officers
4:15pm
8-K
13anfd748s9ffw9nu5
26 Nov 18
Departure of Directors or Certain Officers
5:00pm